Guangxin Xia
11Patents
1h-index
40Co-inventors
50Inventor score
Filing activity: Jun 16, 2008 → Apr 15, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8975252B2 | Morpholine derivative | Chemistry; Metallurgy | 2 | Active |
| US9556159B2 | Renin inhibitor | Chemistry; Metallurgy | 1 | Active |
| US10828305B2 | Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use | Emerging Cross-Sectional Technologies | 1 | Active |
| US9278944B2 | Nitrogen-containing saturated heterocyclic compound | Chemistry; Metallurgy | 0 | Active |
| US10519150B2 | Salts of morpholine derivative, crystal forms thereof, processes for producing the same, pharmaceutical compositions including the same, and use thereof | Chemistry; Metallurgy | 0 | Active |
| US9371292B2 | Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof | Chemistry; Metallurgy | 0 | Active |
| US10870627B2 | Salt of quinazoline derivative, preparation method therefor and application thereof | Chemistry; Metallurgy | 0 | Active |
| US11578074B2 | Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application | Emerging Cross-Sectional Technologies | 0 | Active |
| US10155731B2 | Nitrogen-containing saturated heterocyclic compound | Chemistry; Metallurgy | 0 | Active |
| US10988476B2 | Substituted pyrimidines as cyclin-dependent kinase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US10662186B2 | Substituted pyrimidines as cyclin-dependent kinase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.